Stay updated on Adagrasib + TNO155 in Cancer: KRYSTAL 2 Clinical Trial
Sign up to get notified when there's something new on the Adagrasib + TNO155 in Cancer: KRYSTAL 2 Clinical Trial page.

Latest updates to the Adagrasib + TNO155 in Cancer: KRYSTAL 2 Clinical Trial page
- Check7 days agoChange DetectedThe footer revision identifier changes from v3.7.1 to v3.7.2 while the page continues to display a 403 error.SummaryDifference0.2%

- Check14 days agoChange DetectedThe footer’s ClinicalTrials.gov revision identifier changed from v3.7.0 to v3.7.1, while the page continues to display a 403 error.SummaryDifference0.2%

- Check21 days agoNo Change Detected
- Check34 days agoChange DetectedThe page now displays a 403 Forbidden error instead of the usual study details, showing a generic error screen.SummaryDifference18%

- Check55 days agoChange DetectedThe page’s revision indicator was updated from v3.6.5 to v3.6.6, replacing the previous revision tag to reflect a small update to the page.SummaryDifference0.0%

- Check77 days agoChange DetectedThe page revision has been updated from v3.6.4 to v3.6.5, indicating a new revision release of the study record.SummaryDifference0.0%

- Check91 days agoChange DetectedThe page shows a new revision label v3.6.4, replacing the previous v3.6.3, indicating a small update to the page metadata.SummaryDifference0.0%

Stay in the know with updates to Adagrasib + TNO155 in Cancer: KRYSTAL 2 Clinical Trial
Enter your email address, and we'll notify you when there's something new on the Adagrasib + TNO155 in Cancer: KRYSTAL 2 Clinical Trial page.